These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 9022732
1. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community. Michelow PM, Hlongwane NF, Leiman G. Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732 [Abstract] [Full Text] [Related]
2. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System. Doornewaard H, van de Seijp H, Woudt JM, van der Graaf Y, van den Tweel JG. Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729 [Abstract] [Full Text] [Related]
3. Quality assurance in cervical cytology screening. Comparison of rapid rescreening and the PAPNET Testing System. Halford JA, Wright RG, Ditchmen EJ. Acta Cytol; 1997; 41(1):79-81. PubMed ID: 9022730 [Abstract] [Full Text] [Related]
5. Clinical validation of interactive cytologic screening. Automating the search, not the interpretation. Mango LJ. Acta Cytol; 1997; 41(1):93-7. PubMed ID: 9022733 [Abstract] [Full Text] [Related]
6. PAPNET-assisted rescreening of cervical smears: cost and accuracy compared with a 100% manual rescreening strategy. O'Leary TJ, Tellado M, Buckner SB, Ali IS, Stevens A, Ollayos CW. JAMA; 1998 Jan 21; 279(3):235-7. PubMed ID: 9438746 [Abstract] [Full Text] [Related]
8. Evaluation of the PAPNET system in a general pathology service. Farnsworth A, Chambers FM, Goldschmidt CS. Med J Aust; 1996 Oct 21; 165(8):429-31. PubMed ID: 8913244 [Abstract] [Full Text] [Related]
9. Detection of unsuspected abnormalities by PAPNET-assisted review. Mitchell H, Medley G. Acta Cytol; 1998 Oct 21; 42(1):260-4. PubMed ID: 9479349 [Abstract] [Full Text] [Related]
10. PAPNET testing for HSILs. The few cell/small cell challenge. Solomon HM, Frist S. Acta Cytol; 1998 Oct 21; 42(1):253-9. PubMed ID: 9479348 [Abstract] [Full Text] [Related]
15. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year. Nieminen P, Hakama M, Viikki M, Tarkkanen J, Anttila A. Int J Cancer; 2003 Jan 20; 103(3):422-6. PubMed ID: 12471627 [Abstract] [Full Text] [Related]
16. PAPNET for cervical cytology screening. Experience in Greece. Veneti S, Papaefthimiou M, Symiakaki H, Ioannidou-Mouzaka L. Acta Cytol; 1999 Jan 20; 43(1):30-3. PubMed ID: 9987447 [Abstract] [Full Text] [Related]
18. PAPNET analysis of reportedly negative smears preceding the diagnosis of a high-grade squamous intraepithelial lesion or carcinoma. Sherman ME, Mango LJ, Kelly D, Paull G, Ludin V, Copeland C, Solomon D, Schiffman MH. Mod Pathol; 1994 Jun 20; 7(5):578-81. PubMed ID: 7937724 [Abstract] [Full Text] [Related]
19. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica. Sherman ME, Schiffman M, Herrero R, Kelly D, Bratti C, Mango LJ, Alfaro M, Hutchinson ML, Mena F, Hildesheim A, Morales J, Greenberg MD, Balmaceda I, Lorincz AT. Cancer; 1998 Oct 25; 84(5):273-80. PubMed ID: 9801201 [Abstract] [Full Text] [Related]
20. Evaluation of the PAPNET system for prescreening triage of cervicovaginal smears. Ashfaq R, Saliger F, Solares B, Thomas S, Liu G, Liang Y, Saboorian MH. Acta Cytol; 1997 Oct 25; 41(4):1058-64. PubMed ID: 9250299 [Abstract] [Full Text] [Related] Page: [Next] [New Search]